Europe Flow Cytometry Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Flow Cytometry is a type of technology that is used to analyse the physical and chemical characteristics of particles in a fluid as it passes through at least one laser. Cell components are fluorescently characterised and then excited by the laser to emit light at varying wavelengths. The flow Cytometry technology is widely used in various fields of academic and clinical research, and diagnosis of diseases such as cancer, haematological malignancies, and HIV.

Europe Flow Cytometry Market Segments Size & Growth:

Europe flow cytometry market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Product innovation in reagents for diagnostics, increasing applications of Flow Cytometry in Clinical research, Emergence of new technologies in the field of flow Cytometry, and Stem cell research booming the market growth. However, Reagent based complexities, Expensive equipment’s, and Lack of awareness about the potential benefits of flow Cytometry techniques are thereby hampering the market growth.

Europe Flow Cytometry Market Segments Share:

Europe flow cytometry market is categorised into Type of Product which comprises of Instruments, Systems and Kits, Reagents, Instrument Support Reagents, Fluorospheres, Softwares, and Others. By Technology, the market is segmented into Cell-based Flow Cytometry, Bead-based Flow Cytometry, and Others. By Application, the market is segmented into Clinical Applications, Life Sciences and Biotechnology, and Others. On the basis of End Users, the market is segmented into Pharmaceuticals, CRO, Biotechnology, Academia, Hospitals, and Others. By Geography, UK and Germany are projected to dominate the market with the most significant share and the growth in the Europe economies is mainly attributed because of huge profit margins and growth prospects.

Europe Flow Cytometry Market Trends:

• Luminex Corporation has received FDA clearance for the ARIES Group A Strep Assay, a moderate complexity, the sample to answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the ARIES System.
• Beckman Coulter Life Sciences has opened up the possibilities for cancer researchers with the launch of the first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration.
• Thermo Fisher Scientific Inc., the world leader in serving science, announced that it had completed the acquisition of Phenom-World, a leader in desktop scanning electron microscopy (SEM) solutions.

Europe Flow Cytometry Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major market players, such as

• Beckman Coulter
• Thermo Fisher Scientific, Inc.
• Luminex Corporation
• Bio-Rad Laboratories
• Sony Biotechnology Inc.